Skip to main content
SpringerLink
Log in

Unresolved Questions

  • Chapter
  • First Online:
Lipoprotein(a)

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 489 Accesses

Abstract

It is now almost exactly 60 years since Kare Berg first described an extra pre-β band found in lipid electrophoresis that later was named sinking pre-β and finally Lp(a). There was a continuous up and down in Lp(a) research that was mainly driven by actual research findings related to Lp(a) function, metabolism, correlation to cardiac risk, and epidemiology. The following are four key findings that caused a major boost in the interest for Lp(a) that led to a flurry in publications:

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bittner VA, Szarek M, Aylward PE, Bhatt DL, Diaz R, Edelberg JM, Fras Z, Goodman SG, Halvorsen S, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Moriarty PM, Moryusef A, Pordy R, Roe MT, Sinnaeve P, Tsimikas S, Vogel R, White HD, Zahger D, Zeiher AM, Steg PG, Schwartz GG. Committees OO and investigators. Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome. J Am Coll Cardiol. 2020;75:133–44.

    Google Scholar 

  • Blencowe C, Hermetter A, Kostner GM, Deigner HP. Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein(a) in comparison with low density lipoprotein. J Biol Chem. 1995;270:31151–7.

    Article  CAS  PubMed  Google Scholar 

  • Boffa MB. Beyond fibrinolysis: the confounding role of Lp(a) in thrombosis. Atherosclerosis. 2022;349:72–81.

    Article  CAS  PubMed  Google Scholar 

  • Chennamsetty I, Claudel T, Kostner KM, Baghdasaryan A, Kratky D, Levak-Frank S, Frank S, Gonzalez FJ, Trauner M, Kostner GM. Farnesoid X receptor represses hepatic human APOA gene expression. J Clin Invest. 2011;121:3724–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chennamsetty I, Kostner KM, Claudel T, Vinod M, Frank S, Weiss TS, Trauner M, Kostner GM. Nicotinic acid inhibits hepatic APOA gene expression: studies in humans and in transgenic mice. J Lipid Res. 2012;53:2505–412.

    Article  Google Scholar 

  • Frank S, Hrzenjak A, Blaschitz A, Dohr G, Kostner GM. Role of various tissues in apo(a) fragmentation and excretion of fragments by the kidney. Eur J Cin Invest. 2001;31:504–12.

    Article  CAS  Google Scholar 

  • Gencer BG, Giugliano RP, Tang M, Mach F, Stroes ES, Gouni-Berthold I, Ceska R, Ezhov M, Jukema JWW, Jensen H, Tokgozoglu LS, Huber K, Sabatine MS, O’Donoghue ML. Clinical safety outcomes in relation to lipoprotein(a) concentrations: insights from the FOURIER trial. Circulation. 2021;144(Suppl_1):A11043.

    Article  Google Scholar 

  • Gorges R, Hofer G, Sommer A, Stutz H, Grillhofer H, Kostner GM, Paltauf F, Hermetter A. Transfer of phospholipase A-resistant pyrene-dialkyl-glycerophosphocholine to plasma lipoproteins: differences between Lp[a] and LDL. J Lipid Res. 1995;36:251–9.

    Article  CAS  PubMed  Google Scholar 

  • Graham MJ, Viney N, Crooke RM, Tsimikas S. Antisense inhibition of apolipoprotein(a) to lower plasma lipoprotein(a) levels in humans. J Lipid Res. 2016;57:340–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hermann PM, Watson SN, Wildering WC. Phospholipase A2—nexus of aging, oxidative stress, neuronal excitability, and functional decline of the aging nervous system? Insights from a snail model system of neuronal aging and age-associated memory impairment. Front Genet. 2014;5:419. https://doi.org/10.3389/fgene.2014.00419.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Joshi PK, Pirastu N, Kentistou KA, Fischer K, Hofer E, Schraut KE, Wilson JF. Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity. Nat Commun. 2017;8(1):910. https://doi.org/10.1038/s41467-017-00934-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA. 2009;301:2331–9.

    Article  CAS  PubMed  Google Scholar 

  • Koren MJ, Moriarty PM, Neutel J, Baum SJ, Hernandez-Illas M, Weintraub HS, et al. Abstract 13951: Safety, tolerability and efficacy of single-dose Amg 890, a novel Sirna targeting Lp(a), in healthy subjects and subjects with elevated Lp(a). Circulation. 2020;142(Suppl_3):A13951.

    Article  Google Scholar 

  • Kostner GM, Gavish D, Leopold B, Bolzano K, Weintraub MS, Breslow JL. HMG-CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation. 1989;1989(80):1313–0.

    Article  Google Scholar 

  • Kostner GM, Wo X, Frank S, Zimmermann R, Steyrer E. Metabolism of Lp(a): assembly and excretion. Clin Genet. 1997;52:347–54.

    Article  CAS  PubMed  Google Scholar 

  • Kostner KM, Kostner GM, Wierzbicki AS. Is Lp(a) ready for prime time use in the clinic? A pros-and-cons debate. Atherosclerosis. 2018;274:16–22.

    Article  CAS  PubMed  Google Scholar 

  • Krempler F, Kostner G, Bolzano K, Sandhofer F. Lipoprotein(a) is not a metabolic product of other lipoproteins containing apolipoprotein B. Biochim Biophys Acta. 1979;575:63–70.

    Article  CAS  PubMed  Google Scholar 

  • Krempler F, Kostner GM, Bolzano K, Sandhofer F. Turnover of lipoprotein(a) in man. J Clin Invest. 1980;65:1483–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kronenberg F. Lipoprotein(a) measurement issues: are we making a mountain out of a molehill? Atherosclerosis. 2022;349:123–35.

    Article  CAS  PubMed  Google Scholar 

  • McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987;330(6144):132–7.

    Article  CAS  PubMed  Google Scholar 

  • Moriarty PM, Gray JV, Gorby LK. Lipoprotein apheresis for lipoprotein(a) and cardiovascular disease. J Clin Lipidol. 2019;13(6):894–900.

    Article  PubMed  Google Scholar 

  • O’Donoghue M, Fazio S, Stroes E, et al. Lipoprotein(a), PCSK9 inhibition and cardiovascular risk. Insights from the Fourier trial. Circulation. 2019;39:1483–92.

    Article  Google Scholar 

  • O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79(2):315–28.

    Article  CAS  PubMed  Google Scholar 

  • Pagnan A, Kostner G, Braggion M, Ziron L. Relationship between ‘sinking pre-beta-lipoprotein’ (Lp(a) lipoprotein) and age in a family kindred. Gerontology. 1982;28(6):381–5.

    Article  CAS  PubMed  Google Scholar 

  • Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest. 1992;89:1040–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sattler W, Kostner GM, Waeg G, Esterbauer H. Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins. Biochim Biophys Acta. 1991;1081:65–74.

    Article  CAS  PubMed  Google Scholar 

  • Scharnagl H, Stojakovic T, Dieplinger B, Dieplinger H, Erhart G, Kostner GM, Herrmann M, et al. Comparison of lipoprotein(a) serum concentrations measured by six commercially available immunoassays. Atherosclerosis. 2019;289:206–13.

    Article  CAS  PubMed  Google Scholar 

  • Schmidt K, Kraft HG, Parson W, Utermann G. Genetics of the Lp(a)/apo(a) system in an autochthonous Black African population from the Gabon. Eur J Hum Genet. 2006;14:190–201.

    Article  CAS  PubMed  Google Scholar 

  • Schulter V, Koolwijk P, Peters E, Frank S, Hrzenjak A, Graier WF, van Hinsbergh VW, Kostner GM. Impact of apolipoprotein(a) on in vitro angiogenesis arteriosclerosis. Thromb Vasc Biol. 2001;21(3):433–8.

    Article  CAS  Google Scholar 

  • Schwartz GG, Steg GG, Szarek M, et al. Peripheral artery disease and venous thromboembolic events after acute coronary syndrome. Role of lipoprotein(a) and modification by alirocumab. Prespecified analysis of the Odyssey outcomes randomized clinical trial. Circulation. 2020;141:1608–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sukocheva O, Menschikowski M, Hagelgans A, Yarla NS, Siegert G, Reddanna P, Bishayee A. Current insights into functions of phospholipase A2 receptor in normal and cancer cells: more questions than answers. Semin Cancer Biol. 2019;56:116–27.

    Article  CAS  PubMed  Google Scholar 

  • Szarek M, Bittner V, Aylward P, et al. Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of LDL lowering: ODYSSEY OUTCOMES trial. Eur Heart J. 2020;75:133–44.

    Google Scholar 

  • Utermann G. Lipoprotein(a). In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001. p. 2753–87.

    Google Scholar 

  • Viney NJ, van Capelleveen JC, Geary RS, Xia S, Tami JA, Yu RZ, et al. Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials. Lancet. 2016;388(10057):2239–53.

    Article  CAS  PubMed  Google Scholar 

  • Wood WG, Schumacher M. Lipoprotein(a) concentrations in non-selected hospitalized patient between 18 and 100 years of age: comparison with cholesterol fractions and triacylglycerols in patients with lipid status requests. Eur J Clin Chem Clin Biochem. 1995;33:903–14.

    CAS  PubMed  Google Scholar 

  • Yeang C, Witztum JL, Tsimikas S. Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements. J Lipid Res. 2021;62:100053–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zuliani G, Bader G, Imbastaro T, Mezzetti A, Taddeo U, Kostner GM, Fellin R. Lipoprotein(a) plasma levels and apo(a) isoforms are not associated with longevity or disability in a sample of Italian octo-nonagenarians. Associazione Medica Sabin. Aging. 1995;7(5):385–91.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria

    Gerhard M. Kostner

  2. Department of Cardiology, Mater Hospital and University of Queensland, Brisbane, Australia

    Karam Kostner

Authors
  1. Gerhard M. Kostner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karam Kostner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerhard M. Kostner .

Editor information

Editors and Affiliations

  1. Mater Hospital, University of Queensland, Brisbane, QLD, Australia

    Karam Kostner

  2. Medical University of Graz, Graz, Austria

    Gerhard M. Kostner

  3. Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Peter P. Toth

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kostner, G.M., Kostner, K. (2023). Unresolved Questions. In: Kostner, K., Kostner, G.M., Toth, P.P. (eds) Lipoprotein(a). Contemporary Cardiology. Humana, Cham. https://doi.org/10.1007/978-3-031-24575-6_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-24575-6_25

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-031-24574-9

  • Online ISBN: 978-3-031-24575-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation